Average Co-Inventor Count = 3.12
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genvec, Inc. (18 from 88 patents)
2. National Institutes of Health, a Component of the US Dept. of Health & Human Services (2 from 3,435 patents)
3. Cornell Research Foundation Inc. (1 from 1,521 patents)
4. Genvex, Inc. (1 from 1 patent)
20 patents:
1. 11359214 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use
2. 11034975 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
3. 10792376 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
4. 10787682 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use
5. 10640776 - Method for propagating adenoviral vectors encoding inhibitory gene products
6. 10272162 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
7. 10260074 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
8. 10059962 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use
9. 9725738 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
10. 9629906 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
11. 9617560 - Simian (gorilla) adenovirus or adenoviral vectors and methods of use
12. 9580476 - Adenoviral vector-based respiratory syncytial virus (RSV) vaccine
13. 9388429 - Method for propagating adenoviral vectors encoding inhibitory gene products
14. 9233153 - Affenadenovirus (gorilla) or adenoviral vectors and methods of use
15. 8454972 - Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen